Michelle Lazzaro

Michelle Lazzaro is a Senior Scientist at Arcellx, where leadership in preclinical efforts focuses on evaluating CAR-T therapies for solid tumors. Prior to this role, Michelle served as a Scientist at AstraZeneca, leading in vitro evaluations of novel T cell-engaging modalities and collaborating on human tumor xenograft models. Early career experience includes evaluating immuno-oncology strategies at AstraZeneca, assessing cancer vaccine efficacy at MedImmune, and conducting research on non-muscle myosin II in the University of Maryland lab. Michelle's foundational research involved sequencing efforts for HIV samples at the U.S. Military HIV Research Program. Academic qualifications include a Master of Science and a Bachelor of Science in Biological Sciences from the University of Maryland.